(RED) Talks—Empowered Partners: ViiV Healthcare
We’re back with another episode of (RED) Talks, our digital series of frank conversations exploring the current state of the fight against HIV/AIDS, its impact on marginalized communities, and present opportunities to shine a spotlight on the need for investment.
Many of the biggest challenges facing the HIV/AIDS fight, including access and equity, are too great for any single organization or company to solve.
Only by working together are we able to make 1+1=3. In this episode of (RED) Talks, Deborah Waterhouse, CEO of ViiV Healthcare and President of GSK Global Health, joins Jennifer Lotito, President and COO of (RED), to explore the power of partnership in the fight against HIV and AIDS.
This series is generously sponsored by ViiV Healthcare.
- Key questions addressed in this episode:
- – The average life expectancy of somebody living with HIV has changed exponentially. What impact has this had in shaping Deborah Waterhouse’s career? What’s changed and what hasn’t in the AIDS fight?
- – How did Deborah Waterhouse’s broad range of experience help shape her career and forge her leadership style?
- – What advice could be given to young women and girls who are hoping to get into the life science field and someday climb the corporate ladder?
- – What are the origins of the ViiV model and what prompted GSK and Pfizer to establish an HIV and AIDS-focused business?
- – What does the word partnership mean to Deborah Waterhouse and how is ViiV Healthcare advancing the value of partnership?
- – What is encouraging Deborah Waterhouse in the AIDS fight?